Mind the gap understanding the effects of pharmaceutical direct-to-consumer advertising

Medical Care

Volumn 52, Issue 4, 2014, Pages 291-293

  Fain, Kevin M ^a   Alexander, G Caleb ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRESCRIPTION DRUG; ANTIDEPRESSANT AGENT; CELECOXIB; OXYCODONE;

CONSUMER; DRUG MARKETING; FOOD AND DRUG ADMINISTRATION; HUMAN; PRIORITY JOURNAL; REVIEW; CLINICAL RESEARCH; DIRECT-TO-CONSUMER ADVERTIZING; DRUG INDUSTRY; DRUG LABELING; GENERAL PRACTITIONER; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; PHARMACY; PUBLIC HEALTH; RISK BENEFIT ANALYSIS; CLINICAL PRACTICE; DOCTOR PATIENT RELATION; FEMALE; MALE; NOTE; PATIENT ATTITUDE; STATISTICS;

FEMALE; HUMANS; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS;

EID: 84904856223     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. US Food and Drug Administration. Draft Guidance for Industry: Consumer-Directed Broadcast Advertisements. Notice of Availability. August 12, 1997. Available at: http://www.gpo.gov/fdsys/pkg/FR-1997-08-12/pdf/97-21291.pdf. Accessed February 8, 2014.
2. US Food and Drug Administration. Notice of public hearing; request for comments. August 16, 1995. Available at: http://www.gpo.gov/fdsys/ pkg/FR-1995-08-16/pdf/95-20314.pdf. Accessed February 8, 2014.
3. Stuart Eliot. The media business: Advertising; a seminar examines the plethora of prescription drug pitches since regulations were loosened. The New York Times. June 15, 1998. Available at http://www.nytimes.com/ 1998/06/15/business/media-business-advertising-seminar-examines-plethora- prescription-drug-pitches.html. Accessed February 8, 2014.
4. Komfield R, Donohue J, Bemdt ER, et al. Promotion of prescription drugs to consumers and providers, 2001-2010. PLOS One. 2013;8:e55504.
5. The Pew Charitable Trusts. Persuading the prescribers: Pharmaceutical industry marketing and its influence on physicians and patients. November 11, 2013. Available at: http://www.pewhealth.org/other-resource/persuading-the- prescribers-pharmaceutical-industry-marketing-and-its-influence-on-physicians- and-patients-85899439814. Accessed February 8, 2014.
6. Frosch DL, Grande D, Tam DM, et al. A decade of controversy: Balancing policy with evidence in the regulation of prescription drug advertising. Am J Public Health. 2010;100:24-32.
7. Gilbody S, Wilson P, Watt I. Benefits and harms of direct to consumer advertising: A systematic review. Qual Saf Health Care. 2005;14:246-250.
8. Frosch DL, Krueger PM, Hornik RC, et al. Creating demand for prescription drugs: A content analysis of television direct-to-consumer advertising. Ann Fam Med. 2007;5:6-13.
9. Faerber AE, Kreling DH. Content analysis of false and misleading claims in television advertising for prescription and nonprescription drugs. J Gen Intern Med. 2013;29:110-118.
10. US Food and Drug Administration. The impact of direct-to-consumer advertising. Available at: http://www.fda.gov/Drugs/ResourcesForYou/ Consumers/ucm143562.htm. Accessed February 8, 2014.
11. US Food and Drug Administration. Office of Prescription Drug Promotion (OPDP) Research. Available at: http://www.fda.gov/AboutFDA/CentersOffices/ OfficeofMedicalProductsandTobacco/CDER/ ucm090276.htm. Accessed February 8, 2014.
12. Kravitz RL, Epstein R, Feldman MD, et al. Influence of patients requests for directly advertised antidepressants: A randomized controlled trial. JAMA. 2005;293:1995-2002.
13. Herzenstein M, Misra S, Posavac SS. How consumers) attitudes toward direct-to-consumer advertising of prescription (bugs influence ad effectiveness, and consumer and physician behavior. Marketing Letters. 2004;15:201-212.
14. McKinlay JB, Trachtenberg F, Marceau LD, et aL Effects of patient medication requests on physician prescribing behavior results of a factorial experiment. Med Care. 2014;52:294-299.
15. Alexander GC, Kruszewski SP, Webster DW. Rethinking opioid prescribing to protect patient safety and public health. JAMA. 2012;308:1865-1866.
16. Peabody JW, Luck J, Glassman P, et al. Comparison of vignettes, standardized patients, and chart abstraction: A prospective validation study of 3 methods for measuring quality. JAMA. 2000;283:1715-1722.
17. US Food and Drag Administration. Transcript of direct-to-consumer promotion public hearing-introduction. October 18, 1995. Available at: http://www.fda.gov/aboutfda/centersoffices/officeofmedicalproduct-sandtobacco/ cder/ucm092224.htm. Accessed February 8, 2014.
18. US Food and Drag Administration. Guidance for industry. Consumer-Directed Broadcast Advertisements. Questions and answers. August 1999. Available at http://www.fda.gov/downloads/Drags/GuidanceCompliance RegulatoryInformation/ Guidances/ucm122825.pdf. Accessed February 8, 2014.